Valuation (76%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 15.36 | 12.82 |
| PEG Ratio (TTM) | -0.45 | 1.73 |
| P/S Ratio (TTM) | 1.41 | 2.68 |
| P/B Ratio (TTM) | 0.88 | 1.74 |
| P/FCF Ratio (TTM) | 15.75 | -12.64 |
| Price to 5YR AVG Earnings Ratio | 9.34 | 9.17 |
| Price to 5YR AVG FCF Ratio | 8.71 | 6.04 |
Profitability (40%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.49% | 1.68% |
| ROE (TTM) | 5.74% | 16.43% |
| Net Profit Margin (TTM) | 9.01% | 23.27% |
| ROIC 5YR AVG | 40.22% | 15.12% |
Growth (77%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -17.04% | 95.22% | 65.23% |
| Revenue | 14.08% | 7.74% | 11.37% |
| Net Income | -16.67% | 95.74% | 65.19% |
| Cash Flow | 1,615.34% | 731.99% | 454.76% |
Health (53%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.38 | 6.32 |
| Quick Ratio (TTM) | 2.38 | 6.42 |
| D/E Ratio (TTM) | 0.59 | 1.58 |
| Interest Coverage (TTM) | 1.02 | 0.81 |
| Piotroski F-Score | 5 | 6 |
| Altman Z-Score | 0.89 | 0.45 |
| LTL to 5YR AVG FCF | 5.78 | 7.83 |
| Shares Outstanding Growth 5YR AVG | -0.35% | 1,894.82% |